Beauty Firms Face Adverse Event Reporting, GMP Requirements Under Bill

A discussion draft of the Food and Drug Administration Globalization Act of 2008 in circulation proposes to mandate adverse event reporting, good manufacturing processes and registration with FDA for cosmetic facilities serving American consumers

More from Archive

More from HBW Insight